| Literature DB >> 26375968 |
Bruno Kenway1, Yu Chuen Tam, Zebunnisa Vanat, Frances Harris, Roger Gray, John Birchall, Robert Carlyon, Patrick Axon.
Abstract
OBJECTIVE: To assess differences in pitch-ranking ability across a range of speech understanding performance levels and as a function of electrode position. STUDYEntities:
Mesh:
Year: 2015 PMID: 26375968 PMCID: PMC4588601 DOI: 10.1097/MAO.0000000000000845
Source DB: PubMed Journal: Otol Neurotol ISSN: 1531-7129 Impact factor: 2.311
Comparisons between good and poor performers (averages shown, range in brackets)
| Measure | Good performers (n = 10) | Poor performers (n = 12) |
| BKB | 98 (91–100) | 43 (8–55) |
| VCV | 81 (75–90) | 36 (1–54) |
| Age | 61 (48–77) | 69 (49–78) |
| Duration of deafness | 31 (12–51) | 25 (4–61) |
| Time since implantation | 6 (1.5–14) | 4 (1.5–14) |
| 5/5 Pitch pairs | 71% (19–100) | 37% (0–90) |
| 0/5 Pitch pairs | 9% (0–27) | 5% (0–14) |
| Overall proportion correct pairs | 80% (57–100) | 62% (41–98) |
BKB indicates Bamford-Kowal-Bench; VCV, vowel consonant vowel.
Comparisons between good and poor performers for subjective questionnaires (averages shown, range in brackets)
| Questionnaire | Good performers | Poor performers |
| Glasgow Benefit Inventory | 66 (54–72) | 65 (44–87) |
| Hearing Handicap | 35 (8–58) | 45 (0–84) |
| Tinnitus Handicap | 9 (0–48) | 15 (0–66) |
| Dizziness Handicap | 8 (0–36) | 13 (0–62) |
| HADS | 8 (0–14) | 6 (0–18) |
HADS indicates Hospital Anxiety and Depression Score.
Summary of poor performers (demographics and pitch ranking)
| Patient | BKB/VCV | Implant | Age | Duration deafness (years) | Cause | Time since implantation | Number 5/5 pairs | Number pairs scoring 1, 2, 3, or 4/5 | Number 0/5 pairs | Overall number correct pairs |
| 1 | 52%, 38% | MED-EL | 59 | 31 | Unknown | 3 years | 6/11 | 4/11 | 1/11 | 45/55 |
| 2 | 32%, 33% | AB | 72 | 12 | ?stroke | 1 year | 0/15 | 14/15 | 1/15 | 31/75 |
| 3 | 45%, 35% | AB | 66 | 26 | Progressive ?cause | 1 year | 0/15 | 14/15 | 1/15 | 39/75 |
| 4 | 36%, 35% | AB | 71 | 61 | Unknown | 3 years | 3/15 | 12/15 | 0/15 | 28/45 |
| 5 | 41%, 54% | MED-EL | 76 | 47 | CSOM, multiple mastoid ops | First implant 14 years; reimplant 2005 | 9/11 | 1/11 | 1/11 | 47/55 |
| 6 | 8%, 1% | MED-EL | 49 | 42 | Measles | 5 years | 1/10 | 9/10 | 0/10 | 28/50 |
| 7 | 54%, 44% | MED-EL | 81 | 34 | Unknown ?familial | 4 years | 1/11 | 9/11 | 1/11 | 30/55 |
| 8 | 17%, 20% | MED-EL | 70 | 16 | Streptomycin | 6 years | 6/9 | 3/9 | 0/9 | 39/45 |
| 9l | 55%, 39% | AB | 70 | 4 | Unknown | 3 years | 9/10 | 1/10 | 0/10 | 49/50 |
| 10 | 39%, 33% | Nucleus | 74 | Profound 15 years, some since age 18 | Progressive ?otosclerosis | 2 years | 6/21 | 13/21 | 2/21 | 60/105 |
| 11 | 55%, 38% | Nucleus | 78 | 38 | Progressive | 1 year | 10/21 | 11/21 | 0/21 | 84/105 |
| 12 | 41%, 43% | MED-EL | 71 | Profound 10 years, some loss 30 years | Progressive ?otosclerosis | 5 years | 2/7 | 4/7 | 1/7 | 24/35 |
BKB indicates Bamford-Kowal-Bench; VCV, vowel consonant vowel; AB, Advanced Bionics; ?, not certain; CSOM, chronic suppurative otitis media.
Summary of good performers (demographics and pitch ranking)
| Patient | BKB/VCV | Implant | Age | Duration deafness (years) | Cause | Time since implantation | Number 5/5 pairs | Number pairs scoring 1, 2, 3, or 4/5 | Number 0/5 pairs | Overall number correct pairs |
| 1 | 99%, 85% | MED-EL | 55 | 39 | Unknown | 6 years | 9/9 | 0/9 | 0/9 | 45/45 |
| 2 | 97%, 83% | MED-EL | 50 | 45 | Measles | 5 years | 9/11 | 0/11 | 2/11 | 45/55 |
| 3 | 100%,79% | MED-EL | 48 | 12 | Head injury | 6 years | 5/11 | 3/11 | 3/11 | 31/55 |
| 4 | 99%, 75% | AB | 67 | 38 | Otosclerosis | 3 years | 12/15 | 3/15 | 0/15 | 69/75 |
| 5 | 97%, 90% | AB | 64 | 30 | Progressive | 1.5 years | 15/15 | 0/15 | 0/15 | 75/75 |
| 6 | 99%, 80% | Nucleus | 61 | 51 | Unknown | 1 years | 4/21 | 14/21 | 3/21 | 60/105 |
| 7 | 98%, 71% | Nucleus | 68 | Profound 18 years, some loss 50 years | Unknown | First implant 1994; reimplanted 2007 | 13/21 | 8/21 | 0/21 | 92/105 |
| 8 | 91%, 85% | MED-EL | 77 | 15 | Meningitis | First implant 1994; reimplanted 2005 | 9/11 | 1/11 | 1/11 | 49/55 |
| 9 | 97%, 79% | AB | 49 | 20 | Progressive | 1.5 years | 13/18 | 4/18 | 1/18 | 75/90 |
| 10 | 96%, 85% | AB | 58 | 13 | Unknown | 1.5 years | 11/15 | 4/15 | 0/15 | 70/75 |
BKB indicates Bamford-Kowal-Bench; VCV, vowel consonant vowel; AB, Advanced Bionics.
FIG. 2(A) The abscissa shows the more apical member of the adjacent pairs to be discriminated. The solid blue line shows the average score out of 5, as a function of electrode position, for the 10 users of the MED-EL device who took part. Error bars show +/− one standard error. Missing values have been replaced by the mean score for each subject. The dashed red line shows the average score only for the seven subjects for whom there were no missing data. (B) The total number of listeners scoring 0/5 for each electrode pair.